Sign in
4

Changes in Ownership

Roivant Sciences Ltd. Filed Acc 0001140361-26-036246

Director sold 20,000 shares at $39.90 ($798,000)

  • Director acquired 20,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Fitzgerald Meghan Director 2026-09-08 Option exercise 10b5-1 +20,000 $8.80 $176,000 62,963 D
Fitzgerald Meghan Director 2026-09-08 Sale 10b5-1 −20,000 $39.90 $798,000 42,963 D
Derivatives
Fitzgerald Meghan Director 2026-09-08 Option exercise · Stock Option (Right to Buy) 10b5-1 −20,000 18,578 D
Open-market sales · 20,000 sh · avg $39.90 · $798,000
Loading xslF345X06/form4.xml…